PharmX Technologies Limited
AASX:PHX0.07
AUD
+0.00
(+2.86%)
ISIN
AU0000298762
Return %
Stock
S&P 500
1Y
-42.40
14.20
3Y
67.44
81.12
5Y
-12.20
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Tom Culver
- Full Time Employees
- 9
- Sector
- Technology services
- Industry
- Information technology services
- Address
- 1 Castlereagh Street Sydney NSW Australia 2000
- IPO Date
- Jul 28, 1971
- Website
- pharmx.com.au
- Similar Companies
- Business
- PharmX Technologies Limited operates as a health technology and software provider focusing on the Australian and New Zealand pharmacy sector. The company develops and delivers integrated digital solutions including pharmacy management software, electronic ordering gateways, supplier marketplaces, and data analytics services to improve ordering accuracy, operational efficiency, and market visibility for pharmacies and suppliers. Headquartered in Sydney, Australia, PharmX was founded in 1950 and serves customers across Australia and neighboring markets, with a portfolio that spans Gateway for B2B pharmacy-supplier connectivity, Marketplace for product promotion and procurement, and Analytics for supplier performance and pharmacy operations insights. The business primarily targets independent and chain pharmacies, wholesalers, and suppliers, offering products and services designed to streamline point-of-sale, dispensing, invoicing, and supply chain workflows. Recent developments include the expansion of the supplier ecosystem through the introduction of a dedicated Supplier Portal, enhancements to real-time analytics, and ongoing network growth to broaden market access and trading efficiency. Subsidiaries and corporate reorganizations support a unified Health Services segment that emphasizes software-as-a-service and hardware-enabled solutions for the pharmacy channel. The group emphasizes regional expansion within Australia and New Zealand, maintaining local support and implementation capabilities to service regulatory and operational requirements. PharmX operates under the brand and product suite focused on The Gateway, Marketplace, and Data & Analytics offerings, with ongoing initiatives to integrate suppliers, optimize trade flows, and deliver data-driven decision support to pharmacy customers. The company maintains a public profile on the Australian Securities Exchange under the PHX.AX ticker, reflecting ongoing reporting and corporate governance standards.